We are live on ! Find out more
ATNM icon

Actinium Pharmaceuticals
ATNM

48 hedge funds and large institutions have $15.6M invested in Actinium Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 14 increasing their positions, 5 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

180% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 5

78% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 9

17% more funds holding

Funds holding: 41 → 48 (+7)

17% more call options, than puts

Call options by funds: $3.16M | Put options by funds: $2.7M

2.81% less ownership

Funds ownership: 17.56% → 14.75% (-2.8%)

32% less capital invested

Capital invested by funds: $23.1M → $15.6M (-$7.48M)

Holders
48
Holders Change
+7
Holders Change %
+17.07%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
14
Reduced
5
Closed
9
Calls
$3.16M
Puts
$2.7M
Net Calls
+$458K
Net Calls Change
-$396K

Top Buyers

Rank Fund Capital Flow
1
RCMNY
Rubric Capital Management (New York)
New York
+$2.58M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$697K
3
Millennium Management
Millennium Management
New York
+$598K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$590K
5
Simplex Trading
Simplex Trading
Illinois
+$356K

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$7.66M
2
SCM
Sio Capital Management
New York
-$1.83M
3
JGC
J. Goldman & Co
New York
-$1.64M
4
Morgan Stanley
Morgan Stanley
New York
-$331K
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$276K
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Advisers
26
Two Sigma Advisers
New York
$78K +$109K +10,000 New
PNC Financial Services Group
27
PNC Financial Services Group
Pennsylvania
$52K – – –
Bank Julius Baer & Co
28
Bank Julius Baer & Co
Switzerland
$32K -$11.2K -1,028 -20%
Rockefeller Capital Management
29
Rockefeller Capital Management
New York
$29K +$18.2K +1,677 +80%
Morgan Stanley
30
Morgan Stanley
New York
$26K -$331K -30,458 -90%
Carson Wealth (CWM LLC)
31
Carson Wealth (CWM LLC)
Nebraska
$12K – – –
Osaic Holdings
32
Osaic Holdings
Arizona
$9K +$3.96K +365 +41%
LC
33
Lindbrook Capital
California
$8K +$10.9K +1,000 New
HFM
34
Hartford Financial Management
Connecticut
$5K – – –
SFS
35
Sowell Financial Services
Arkansas
$5K +$6.91K +636 New
Bank of America
36
Bank of America
North Carolina
$3K +$3.42K +315 +630%
PCIA
37
Prime Capital Investment Advisors
Kansas
$3K +$4.63K +426 New
GFPC
38
Global Financial Private Client
Florida
$2.08K – – –
TWA
39
TCI Wealth Advisors
Arizona
$2K +$1.09K +100 +100%
GI
40
Gradient Investments
Minnesota
$1K – – –
IA
41
IFP Advisors
Florida
$1K – – –
Northwestern Mutual Wealth Management
42
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
TC
43
Truvestments Capital
Florida
$1K +$2.28K +210 New
GEA
44
Glen Eagle Advisors
New Jersey
$47 – – –
SCM
45
Sio Capital Management
New York
– -$1.83M -189,062 Closed
JGC
46
J. Goldman & Co
New York
– -$1.64M -168,749 Closed
Arrowstreet Capital
47
Arrowstreet Capital
Massachusetts
– -$276K -28,500 Closed
GCP
48
GSA Capital Partners
United Kingdom
– -$134K -13,823 Closed
PP
49
PDT Partners
New York
– -$112K -11,539 Closed
Russell Investments Group
50
Russell Investments Group
United Kingdom
– -$89K -9,200 Closed
1
2
3

ATNM Hedge Fund Activity: Q4 2020 in Review

48 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Actinium Pharmaceuticals (ATNM) for Q4 2020, worth a combined $15.6M — down 32% from $23.1M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new ATNM positions and 9 closed out — a net gain of 7 holders — while 14 added to existing stakes and 5 trimmed.

The largest buyer was Rubric Capital Management (New York), adding an estimated $2.58M. The largest seller was Consonance Capital Management, cutting an estimated $7.66M.

  • 48 institutional investors held Actinium Pharmaceuticals (ATNM) as of Q4 2020, up from 41 in Q3 2020.
  • Funds reported $15.6M of Actinium Pharmaceuticals stock for Q4 2020, down 32% quarter-over-quarter.
  • 16 funds opened new Actinium Pharmaceuticals positions in Q4 2020 and 9 closed out, a net change of +7 holders.
  • The largest Actinium Pharmaceuticals buyer in Q4 2020 was Rubric Capital Management (New York), an estimated $2.58M added.
  • The largest Actinium Pharmaceuticals seller in Q4 2020 was Consonance Capital Management, an estimated $7.66M sold.

Based on aggregated 13F filings for Q4 2020.